DJIA 17,223.58 154.71 0.91%
NASDAQ 4,602.05 54.21 1.19%
S&P 500 1,995.81 23.07 1.17%
market minute promo

Vertex Pharmaceuticals (NASDAQ: VRTX)



company name or ticker
Company Photos
(Click to zoom)

Where Are They Now? A Look Back at the Best & Worst Biotech CEOs

Top Healthcare Stocks for 2014

These 10 stocks were the top large-cap performers in healthcare during 2014.

Why Gilead Sciences and AbbVie Care About This Tiny Company

Achillion Pharmaceuticals is conducting a study that could reduce hepatitis C treatment to six weeks.

Biotech Stock Roundup: Cubist to be Acquired by Merck, Bluebird Shoots Up on ASH Data - Analyst Blog

S&P 500 Movers: NBR, CELG

Nasdaq 100 Movers: VIP, CELG

Time to Buy This Dip in Gilead Sciences, Inc. Stock?

Shares of Gilead Sciences have slipped over the last month. Is now the time to buy this top biotech?

Biotech Stock Roundup: Avanir to be Acquired by Japanese Firm, Biogen Scores in Alzheimer's Study -

Biotech Stock Roundup: Avanir to be Acquired by Japanese Firm, Biogen Scores in Alzheimer's Study - Analyst Blog

Stock Market News for December 03, 2014 - Market News

Great News For Biogen, But What's Next For The Stock?

See More Articles...